Inactive Instrument

Zomedica Corp. Stock Toronto S.E.

Equities

ZOM

CA98980M1095

Healthcare Facilities & Services

Sales 2022 18.93 25.94 Sales 2023 25.19 34.52 Capitalization 196M 269M
Net income 2022 -17M -23.3M Net income 2023 -34M -46.6M EV / Sales 2022 2,449,963 x
Net cash position 2022 113M 155M Net cash position 2023 87.77M 120M EV / Sales 2023 4,304,730 x
P/E ratio 2022
-9.39 x
P/E ratio 2023
-5.68 x
Employees 144
Yield 2022 *
-
Yield 2023
-
Free-Float 98.41%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 67 21-09-30
Director of Finance/CFO 53 23-03-15
Chief Tech/Sci/R&D Officer - 17-12-31
Members of the board TitleAgeSince
Chief Executive Officer 67 21-09-30
Director/Board Member 62 19-08-15
Director/Board Member 66 20-06-15
More insiders
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.
More about the company